Silk Road Medical, Inc (SILK)

22,34 +0,07 (+0,31%) In data: 12:55PM EDT. Mercato aperto.

Silk Road Medical, Inc

1213 Innsbruck Drive
Sunnyvale, CA 94089
United States
408 720 9002
https://silkroadmed.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 474

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Charles S. McKhann	CEO & Director	300,77k	N/D	1969
Mr. Lucas W. Buchanan	CFO & COO	836,87k	4,05M	1978
Mr. Kevin M. Klemz	EVP, Chief Legal Officer & Secretary	665,34k	N/D	1961
Mr. Andrew S. Davis	Chief Commercial Officer	1,2M	1,45M	1969
Mr. Richard M. Ruedy	Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance	476,27k	N/D	1967
Ms. Mhairi L. Jones	Chief Accounting Officer & VP of Finance	N/D	N/D	1971
Ms. Tammy Leitsinger	Compliance Officer & VP of Medical Affairs	N/D	N/D	N/D
Mr. Jorge O'Hara	Vice President of Marketing, Business Development & Strategy	N/D	N/D	N/D
Ms. Alison Highlander	Vice President of Human Resources	N/D	N/D	N/D
Dr. Sumaira MacDonald M.D., Ph.D.	Executive Medical Director	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Governance aziendale

L'ISS Governance QualityScore di Silk Road Medical, Inc al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 5; diritti degli azionisti: 7; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.